IL6R and COVID-19: IL-6, an important player in COVID-19, binds IL-6R and gp130 receptors to activate JAK/STAT-3 pathway and then contributes to the CRS observed in COVID-19 (Zhang et al., 2020) and possibly in Long COVID patients.